• Rewind Therapeutics appoints Biopharmaceutical Industry Veteran Kees Been as Non-Executive Director

    Wednesday September 2nd 2020

  • FOx Biosystems appoints new CEO

    Tuesday September 1st 2020

  • Biocartis Expands Collaboration with LifeArc

    Tuesday September 1st 2020

  • Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)

    Tuesday September 1st 2020

  • V-Bio Ventures invests in Biodol Therapeutics

    Monday August 31st 2020

  • Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases

    Thursday August 27th 2020

  • Vlaanderen investeert ruim kwart miljoen euro in Belgische Google van de genetica

    Wednesday August 26th 2020

  • Persomed Appoints Kristof Vercruysse as CEO to Drive Personalized Cancer Vaccine Venture’s Successful Implementation

    Monday August 24th 2020

  • Your news here?

  • Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis

    Wednesday August 19th 2020

  • Mithra Announces Commercial Launch of Myring™ in the Netherlands

    Wednesday August 19th 2020

  • BioLizard Awarded €300,000 VLAIO Research Grant to Establish Causal Link Between the Microbiome and Disease

    Monday August 17th 2020


Strategic Partners